← Eichor
Study identifier: NCT04179981 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

Condition: Sleep Apnea Syndrome · Obstructive Sleep Apnea · COPD  ·  Sponsor: VA Office of Research and Development

PhaseNA
Planned participants668
Who can joinAll sexes, 60 Years to no upper limit
Healthy volunteersNo

About this study

Obstructive sleep apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD) are highly prevalent chronic respiratory diseases in the Veteran population. OSA co-occurring with COPD, known as Overlap Syndrome (OVS), is a complex chronic medical condition associated with grave consequences. OVS is highly prevalent in Veterans. Veterans with OVS may be at increased risk for cognitive deficits, poor sleep quality as well as a reduced quality of life (QoL). The overall objective is to study the effects of positive airway pressure therapy on clinical outcomes in patients with OVS.

This description comes directly from the study's public registry record.

Talk to the study team

Ruchi Rastogi, MS  ·  (313) 576-4464  ·  ruchi.rastogi@va.gov

Always discuss trial participation with your own doctor first.

Locations (1)

John D. Dingell VA Medical Center, Detroit, MIDetroit, Michigan, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04179981